2022

1. Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study

   World Journal of Urology, Vol. 40, Núm. 10, pp. 2459-2466

2. Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS study

   Neurourology and Urodynamics, Vol. 41, Núm. 8, pp. 1824-1833